Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Country / region: Taiwan Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20161
20181
20193
20201
20211
20221
20232
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Terminated5
Active, not recruiting2
Completed1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AP Biosciences Inc.1
Alentis Therapeutics AG1
Amgen1
Daiichi Sankyo1
DualityBio Inc.1
Genmab1
Hummingbird Bioscience1
Inhibrx Biosciences, Inc1
Janssen Research & Development, LLC1
Kymab Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck17
Carcinoma, Non-Small-Cell Lung11
Melanoma7
Stomach Neoplasms5
Uterine Cervical Neoplasms5
Colorectal Neoplasms4
Carcinoma, Hepatocellular3
Carcinoma, Renal Cell3
Carcinoma, Squamous Cell3
Carcinoma, Transitional Cell3

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.